dr. B.M. (Bettien) van Hemel

dr. B.M. (Bettien) van Hemel
E-mail:
b.m.van.hemel umcg.nl

Research

  1. 2020
  2. 2019
  3. 2018
  4. de Vries, L. H., Lodewijk, L., Willems, S. M., Dreijerink, K. M. A., de Keizer, B., van Diest, P. J., ... Vriens, M. R. (2018). SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival. Endocrine, 62(3), 639-647. https://doi.org/10.1007/s12020-018-1706-1
  5. Lodewijk, L., Willems, S. M., Dreijerink, K. M. A., de Keizer, B., van Diest, P. J., Schepers, A., ... Vriens, M. R. (2018). The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer. Human Pathology, 81, 245-254. https://doi.org/10.1016/j.humpath.2018.06.035
  6. 2017
  7. Lodewijk, L., van Diest, P., van der Groep, P., ter Hoeve, N., Schepers, A., Morreau, J., ... Vriens, M. (2017). Expression of HIF-1 alpha in medullary thyroid cancer identifies a subgroup with poor prognosis. Oncotarget, 8(17), 28650-28659. https://doi.org/10.18632/oncotarget.15622
  8. 2016
  9. 2015
  10. 2014
  11. 2013
  12. 2012
  13. 2011
  14. 2010
  15. 2009

ID: 381597